Valuation: UCB

Market Cap 46.83B 53.33B 43.5B 39.97B 75.14B 5,139B 76.13B 518B 202B 2,526B 200B 196B 8,726B P/E 2026 *
26.4x
P/E 2027 * 20.9x
Enterprise Value 46.59B 53.06B 43.28B 39.77B 74.75B 5,112B 75.74B 515B 201B 2,513B 199B 195B 8,681B EV / Sales 2026 *
5.45x
EV / Sales 2027 * 4.62x
Free-Float
61.59%
Yield 2026 *
0.6%
Yield 2027 * 0.61%
1 day+1.23%
1 week+2.80%
Current month-6.11%
1 month-4.13%
3 months+2.93%
6 months-4.43%
Current year+3.10%
1 week 235.7
Extreme 235.7
249.8
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 177.7
Extreme 177.7
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%+2.80%+38.09%+200.66% 53.32B
+0.63%-3.06%+16.50%-10.12% 66.74B
+10.08%+51.80%+51.80%+51.80% 48.12B
-1.32%-7.38%-57.37%-56.96% 38.25B
+0.78%-1.84%+53.73%-25.20% 29.85B
+0.84%+0.36%+67.62%+84.46% 23.51B
-5.17%-12.54%+58.33%-55.63% 21.45B
-1.21%+1.12%+0.90%+164.17% 19.97B
+1.31%+3.24%+81.47%+157.97% 16.47B
-0.22%-0.95%+62.78%+123.12% 16.38B
Average +0.69%-0.57%+37.38%+63.43% 33.41B
Weighted average by Cap. +1.40%+0.06%+30.72%+54.70%

Financials

2026 *2027 *
Net sales 8.54B 9.73B 7.94B 7.29B 13.71B 938B 13.89B 94.42B 36.88B 461B 36.52B 35.75B 1,592B 9.64B 10.98B 8.96B 8.23B 15.47B 1,058B 15.68B 107B 41.63B 520B 41.22B 40.35B 1,797B
Net income 1.77B 2.02B 1.64B 1.51B 2.84B 194B 2.88B 19.56B 7.64B 95.49B 7.57B 7.41B 330B 2.28B 2.59B 2.12B 1.94B 3.65B 250B 3.7B 25.17B 9.83B 123B 9.73B 9.53B 424B
Net Debt -242M -276M -225M -207M -389M -26.58B -394M -2.68B -1.05B -13.07B -1.04B -1.01B -45.13B -2.32B -2.65B -2.16B -1.98B -3.73B -255B -3.78B -25.67B -10.03B -125B -9.93B -9.72B -433B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-24 €246.00 +1.23% 149,516
26-07-23 €243.00 -0.12% 205,984
26-07-22 €243.30 -0.25% 107,748
26-07-21 €243.90 +2.48% 198,029
26-07-20 €238.00 -0.54% 155,998
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
246.00EUR
Average target price
287.95EUR
Spread / Average Target
+17.05%

Quarterly revenue - Rate of surprise